# Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions

> **NCT04406194** · PHASE1 · COMPLETED · sponsor: **Atabay Kimya Sanayi Ticaret A.S.** · enrollment: 30 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** FAVICOVIR 200 mg Film Tablet
- **DRUG:** AVIGAN 200 mg Film Tablets

## Key facts

- **NCT ID:** NCT04406194
- **Lead sponsor:** Atabay Kimya Sanayi Ticaret A.S.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-14
- **Primary completion:** 2020-05-22
- **Final completion:** 2020-06-19
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04406194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04406194, "Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04406194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*